Jacob P Sunnerberg, David I Hunter, Austin M Sloop, Armin D Tavakkoli, Petr Bruza, Rongxiao Zhang, Jiang Gui, Lesley A Jarvis, Harold M Swartz, David J Gladstone, P Jack Hoopes, Brian W Pogue
{"title":"Timescale of FLASH sparing effect determined by varying temporal split of dose delivery in mice.","authors":"Jacob P Sunnerberg, David I Hunter, Austin M Sloop, Armin D Tavakkoli, Petr Bruza, Rongxiao Zhang, Jiang Gui, Lesley A Jarvis, Harold M Swartz, David J Gladstone, P Jack Hoopes, Brian W Pogue","doi":"10.1016/j.ijrobp.2025.09.052","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine the timescale for ultra-high dose rate (UHDR) radiation delivery that dictates FLASH normal-tissue sparing and elucidate its relationship to in vivo oxygen dynamics. A split-dose experiment was used to determine the transition time below which the observation of the FLASH sparing effect is preserved.</p><p><strong>Methods and materials: </strong>A 25 Gy dose was split into two deliveries (12.5 Gy), with varied interruption times. Albino B6 mice received flank skin irradiation in eight groups: single-beam UHDR (25 Gy at 415 Gy/s), single-beam conventional dose rate (CDR) (25 Gy at 0.15 Gy/s), or split-beam delivery with two lower-dose UHDR beams (12.5 Gy at 415 Gy/s) separated by 0.1, 1, 5, 15, 25, or 120 seconds. Skin damage was scored daily for 31 days, with mixed-effects analysis comparing damage progression across cohorts. Real-time tissue pO<sub>2</sub> was monitored using the phosphorescence-lifetime probe Oxyphor PdG4. Radiolytic oxygen consumption per unit dose (g<sub>O2</sub>) and reoxygenation rates were quantified.</p><p><strong>Results: </strong>Single-beam UHDR significantly spared skin versus CDR. In split-dose groups, this sparing effect showed a transition at longer inter-beam intervals. Damage progression remained significantly lower than CDR and comparable to single-beam UHDR (p>0.16) for interruptions < 15 seconds. Longer intervals progressively lost tissue sparing. Oximetry indicated an average tissue reoxygenation lifetime of 7.7 ± 1.1 s. At the delivery of the second beam, pO<sub>2</sub> remained lower when inter-beam times were shorter than the reoxygenation period but recovered fully for longer interruptions. g<sub>O2</sub> values correlated with baseline tissue pO<sub>2</sub>.</p><p><strong>Conclusions: </strong>Observation of the FLASH sparing effect requires delivery within a critical temporal window that is similar timescale to tissue reoxygenation kinetics. The transition time for loss of the FLASH sparing effect in skin roughly corresponds to a diffusion timescale for oxygen, from capillaries to the cells. While not conclusively demonstrating a mechanism, this unique finding supports the likelihood that local oxygen depletion or consumption underlies the FLASH tissue sparing effect observed in vivo, with important implications for clinical implementation and the timescale needed for multi-beam FLASH-RT.</p>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":" ","pages":""},"PeriodicalIF":6.5000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2025.09.052","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To determine the timescale for ultra-high dose rate (UHDR) radiation delivery that dictates FLASH normal-tissue sparing and elucidate its relationship to in vivo oxygen dynamics. A split-dose experiment was used to determine the transition time below which the observation of the FLASH sparing effect is preserved.
Methods and materials: A 25 Gy dose was split into two deliveries (12.5 Gy), with varied interruption times. Albino B6 mice received flank skin irradiation in eight groups: single-beam UHDR (25 Gy at 415 Gy/s), single-beam conventional dose rate (CDR) (25 Gy at 0.15 Gy/s), or split-beam delivery with two lower-dose UHDR beams (12.5 Gy at 415 Gy/s) separated by 0.1, 1, 5, 15, 25, or 120 seconds. Skin damage was scored daily for 31 days, with mixed-effects analysis comparing damage progression across cohorts. Real-time tissue pO2 was monitored using the phosphorescence-lifetime probe Oxyphor PdG4. Radiolytic oxygen consumption per unit dose (gO2) and reoxygenation rates were quantified.
Results: Single-beam UHDR significantly spared skin versus CDR. In split-dose groups, this sparing effect showed a transition at longer inter-beam intervals. Damage progression remained significantly lower than CDR and comparable to single-beam UHDR (p>0.16) for interruptions < 15 seconds. Longer intervals progressively lost tissue sparing. Oximetry indicated an average tissue reoxygenation lifetime of 7.7 ± 1.1 s. At the delivery of the second beam, pO2 remained lower when inter-beam times were shorter than the reoxygenation period but recovered fully for longer interruptions. gO2 values correlated with baseline tissue pO2.
Conclusions: Observation of the FLASH sparing effect requires delivery within a critical temporal window that is similar timescale to tissue reoxygenation kinetics. The transition time for loss of the FLASH sparing effect in skin roughly corresponds to a diffusion timescale for oxygen, from capillaries to the cells. While not conclusively demonstrating a mechanism, this unique finding supports the likelihood that local oxygen depletion or consumption underlies the FLASH tissue sparing effect observed in vivo, with important implications for clinical implementation and the timescale needed for multi-beam FLASH-RT.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.